Dr Lily Brown describes a GAD patient encounter that showed how reassurance-seeking can be reinforced by clinicians and ...

Topline data from the phase 3 PALISADE-4 trial showed that fasedienol nasal spray did not significantly improve acute anxiety compared with a placebo in the overall SAD population.

Add Yahoo as a preferred source to see more of our stories on Google. Ekaterina Goncharova/Getty Images Almost 20% of US adults deal with one or more anxiety disorders each year, according to ...

Actor Barun Sobti opened up about his ADHD diagnosis, reflecting on childhood behaviors that prompted him to seek assistance.

For youths with anxiety disorders, similar symptom reduction is seen with fluoxetine, cognitive behavioral therapy (CBT), and ...

Anxiety isn’t just about feeling stressed or worried. For millions of Americans it’s a daily battle that affects everything from relationships to career choices. With 31% of adults experiencing an ...

Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product ...

Be sure to scroll down after this story to find links to extensive Medscape Medical News coverage addressing mental health and medical professionals. The nightmares started in his second quarter of ...

Vistagen has chalked up another trial failure for fasedienol, its drug candidate for social anxiety disorder (SAD), cratering ...

Background Evidence from several countries suggests increasing mental health problems among children and adolescents, raising ...

The two most common mental health conditions among older adults are anxiety and depression. Various factors are associated with this, and treatment and support are available. A certain amount of ...